Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2001 | 1 |
2002 | 1 |
2004 | 1 |
2006 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.
J Virol. 2002 Aug;76(16):8475-84. doi: 10.1128/jvi.76.16.8475-8484.2002.
J Virol. 2002.
PMID: 12134052
Free PMC article.
Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor.
Seamon JA, Rugg CA, Emanuel S, Calcagno AM, Ambudkar SV, Middleton SA, Butler J, Borowski V, Greenberger LM.
Seamon JA, et al.
Mol Cancer Ther. 2006 Oct;5(10):2459-67. doi: 10.1158/1535-7163.MCT-06-0339.
Mol Cancer Ther. 2006.
PMID: 17041089
Item in Clipboard
Mutational analysis of the N-terminus of Moloney murine leukemia virus integrase.
Yang F, Seamon JA, Roth MJ.
Yang F, et al. Among authors: seamon ja.
Virology. 2001 Dec 5;291(1):32-45. doi: 10.1006/viro.2001.1218.
Virology. 2001.
PMID: 11878874
Free article.
Item in Clipboard
Differential effects of C-terminal molecular tagged integrase on replication competent moloney murine leukemia virus.
Seamon JA, Adams M, Sengupta S, Roth MJ.
Seamon JA, et al.
Virology. 2000 Sep 1;274(2):412-9. doi: 10.1006/viro.2000.0481.
Virology. 2000.
PMID: 10964783
Free article.
Item in Clipboard
A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.
Emanuel S, Gruninger RH, Fuentes-Pesquera A, Connolly PJ, Seamon JA, Hazel S, Tominovich R, Hollister B, Napier C, D'Andrea MR, Reuman M, Bignan G, Tuman R, Johnson D, Moffatt D, Batchelor M, Foley A, O'Connell J, Allen R, Perry M, Jolliffe L, Middleton SA.
Emanuel S, et al. Among authors: seamon ja.
Mol Pharmacol. 2004 Sep;66(3):635-47. doi: 10.1124/mol.104.000638.
Mol Pharmacol. 2004.
PMID: 15322256
Item in Clipboard
Cite
Cite